PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 77: Articles 38001-38500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Attitudes of medical educators toward integrating family planning with human sexuality.
  2. Atypical endocervical hyperplasia and oral contraceptives: report of a case.
  3. Atypical endocervical hyperplasia in hormonal contraception. [Atypische endozervikale Hyperplasien bei hormoneller Kontrazeption.]
  4. Auxiliary nurse-midwives in family planning.
  5. Background and motivations for family planning. [Antecedentes y motivaciones para la planeacion familiar.]
  6. Bacteriology of the intra-uterine contraceptive device (I.U.C.D.)
  7. Barriers to birth control.
  8. Bed rest, elective surgery, and oral contraceptives. (Letter to the editor)
  9. Behcet's disease: alleviation of buccal and genital ulceration by an oral contraceptive agent.
  10. Beliefs, channels and the family planning message: the Dominican Republic.
  11. Beyond family planning.
  12. Beyond family planning.
  13. A bibliography of studies on target setting for family planning in India and studies on births averted.
  14. Bibliography on the health aspects of human reproduction, population dynamics and family planning and related subjects.
  15. Bilateral contraception with unilateral intra-uterine device in the rat.
  16. Bilateral ruptured tubal pregnancies associated with oral contraceptives.
  17. Birth control - a brief history.
  18. Birth control as preventive medicine.
  19. Birth control experience among pregnant adolescents: the process of unplanned parenthood.
  20. Birth control experience in Taiwan.
  21. Birth control in Catholic countries.
  22. Birth control in Singapore and the IUCD.
  23. Birth control in the third world.
  24. Birth control services and sex counseling at Yale.
  25. Birth control survey in a lower social group in Melbourne.
  26. Birth control vs. family planning.
  27. Birth control and/or "family planning."
  28. Birth control, teenagers, and the law: a new look, 1971.
  29. Birth control: all the methods that work...and the ones that don't.
  30. Birth in the wilds: I and II. (Birth control)
  31. Birth variation in populations which practice family planning.
  32. Births prevented in India through the use of intra-uterine contraceptive device and sterilization.
  33. Black fertility and contraception: from African tribes to American plantations.
  34. Blood clotting and contraception.
  35. Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study.
  36. Blood glucose and plasma insulin levels with ethynodiol diacetate oral contraceptive.
  37. Blood pressure with hormonal contraception.
  38. Blood-pressure in women after 1 year of oral contraception.
  39. Breast cancer and oral contraceptives not linked, British study finds.
  40. Breast-milk jaundice and oral contraceptives.
  41. A brief discussion of the population problems in Iran and the role of medical education in dealing with manpower shortage in Iranian family planning programs.
  42. Budd-Chiari syndrome in women taking oral contraceptives.
  43. C-reactive protein in pregnancy and contraception.
  44. Calcium carbonate deposition on intrauterine contraceptive devices.
  45. Can the prevention of births in India be attributed to the government investment in family planning?
  46. Carbohydrate metabolism and contraceptive steroids. (Congress abstract)
  47. Carbohydrate metabolism in long-term oral contraceptive users.
  48. Carcinoma and oral contraceptives. (Epidemiological aspects, breast cancer, and panel discussion)
  49. A case study of the drop-outs in the oral contraception pilot project, Madras.
  50. Catholic parish priests and birth control: a comparative study of opinion in Colombia, the United States, and the Netherlands.
  51. Catholics and contraception.
  52. Cerebral circulatory disorders during hormonal contraception. [Zerebrale Durchblutungsstoerungen unter hormonalen Kontrazeptiva.]
  53. Cerebral ischaemic lesions and oral contraception.
  54. Cerebral venous thrombosis and oral contraception. [Thrombose veineuse cerebrale et anticonception orale.]
  55. Cerebrovascular disturbances in young women on oral contraceptives? [Hirndurchblutungsstoerungen bei jungen Frauen nach Einnahme von Ovulationshemmern?]
  56. Cervical cytology and histology in patients treated with a combination oral contraceptive in low dosage.
  57. Cervical mucus sperm penetration in women or oral contraception or with an IUD in situ.
  58. Change in family planning activity in the City of Poona (1951-64)
  59. Changes in plasma cholinesterase isoenzymes due to oral contraceptives.
  60. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
  61. Changes occurred in concepts related to contraception during the 1966-1971 period; survey among multiparae of Sorocaba - Sao Paulo. [Modificacoes ocorridas nos conceitos relacionados a anticoncepcao no periodo de 1966-1971; inquerito realizado entre multiparas de Sorocaba - SP.]
  62. Changing family-planning activity in the city of Poona.
  63. Chemical contraception.
  64. Chorea and oral contraceptives. (Letter to the editor)
  65. Chorea and the oral contraceptives.
  66. Chorea associated with oral contraceptive therapy.
  67. Clearance and metabolism of some contraceptive steroids in normal and lactating women.
  68. The clinic observation system: a complete system for assessing respectful treatment of patients at family planning clinics.
  69. Clinical effectiveness of an aerosol contraceptive foam.
  70. A clinical evaluation of a once-a-cycle injectable contraceptive.
  71. Clinical experience with a daily low dose of chlormadinone acetate as an oral contraceptive.
  72. Clinical experience with low dose progestagens in contraception.
  73. Clinical experiences with quinestrol for contraception. [Klinische Erfahrungen mit Quinestrol zur Kontrazeption.]
  74. Clinical symptomatology and endometrial histology in cases of intrauterine contraceptive devices. [Klinicka symptomatologia a endometrialna histologia pri kontraceptivnych telieskach.]
  75. Coagulation studies in haemophilic patients taking oral contraceptives.
  76. Collaborative study of the colorimetric determination of progestational steroids in contraceptive tablets.
  77. Combat pollution with contraception. (Letter)
  78. A "combination method" of family planning.
  79. The commercial distribution of contraceptives in Colombia, Iran, and the Philippines. Report to the Population Council.
  80. Communicating family planning.
  81. Communication in family planning.
  82. Communications in rural family planning.
  83. Communications strategy in the Singapore National Family Planning Programme.
  84. Comparative clinical and morphological studies on 2 oral contraceptives which contain DL-norgestrel and D-norgestrel, respectively. [Vergleichende klinische und morphologische Untersuchungen von zwei oralen Antikonzeptiva, die DL-Norgestrel beziehungsweise D-Norgestrel enthalten.]
  85. Comparative study of new low-dosage pills for oral contraception in Indian women.
  86. Comparison of changes in activity of some hemocoagulation factors during contraception and therapy with combinations of synthetic steroids with varied gestagenic component. [Srovnani zmen aktivity nekterych hemokoagulacnich faktoru v prubehu antikoncepce a lecby kombinacemi syntetickych steroidu s gestagenni slozkou ruzne rady.]
  87. A comparison of family planning programs in Iran and Turkey.
  88. A comparison of the long-acting contraceptive agents norethisterone oenanthate and medroxyprogesterone acetate.
  89. Comprehensive family planning based on maternal/child health services: a feasibility study for a world program.
  90. Conclusions of the ad hoc committee to review the techniques of the Goldzieher placebo-contraceptive study.
  91. Congenital afibrinogenemia: vascular changes and multiple thromboses induced by fibrinogen infusions and contraceptive medication.
  92. Consequences of family planning for man's genetic future.
  93. Consultant's report: designing a study of abortion, National Family Planning Research Institute.
  94. Contact allergic urethritis in man caused by the use of contraceptives.
  95. Continuation of contraception by low income women: a one year follow-up.
  96. Continuous norethindrone, 0.35 mg., as an oral contraceptive agent.
  97. Contraception according to Catholic moral teaching. [La contraception selon la morale catholique.]
  98. Contraception after delivery in Cook County.
  99. Contraception and abortion among Aleuts and Eskimos in Alaska: a demographic study.
  100. Contraception and abortion in Cuba.
  101. Contraception and blood pressure.
  102. Contraception and cancerogenic risks. [Contraception et risques cancerigenes.]
  103. Contraception and psychopathology. [Contraception et psychopathologie.]
  104. Contraception and pulmonary embolism.
  105. Contraception and pulmonary embolism.
  106. Contraception and sterilization in women. [Contraception et sterilisation chez la femme.]
  107. Contraception and Sterilization.
  108. Contraception and the unmarried.
  109. Contraception and thromboembolic vascular complications. [Contraception et accidents vasculaires thrombo-emboliques.]
  110. Contraception by microdose d-norgestrel.
  111. Contraception for sicklers.
  112. Contraception in Moslems living in the Paris area. [La contraception chez les musulmanes vivant dans la region parisienne.]
  113. Contraception throughout the world. [La contraception dans le monde.]
  114. Contraception with a normophasic preparation, Ovanon. [Antikonception med et normofasisk praeparat Ovanon.]
  115. Contraception with a six-monthly injection of progestogen. Part 1. Effects on blood pressure, body weight and uterine bleeding pattern, side effects, efficacy and acceptability.
  116. Contraception with a six-monthly injection of progestogen. Part 2. Effects on cervical mucus secretion and endocrine function.
  117. Contraception with a six-monthly injection of progestogen. Part 3. Effects on the endometrium.
  118. Contraception.
  119. Contraception: clinical experimentation and future perspectives. [La contraception: experimentation clinique et perspectives d'avenir.]
  120. The contraceptive action of impeding oestrogens. I. Activity of oestriol in the rat.
  121. The contraceptive action of impeding oestrogens. II. Post-coital effect of oestriol in the rat.
  122. The contraceptive action of impeding oestrogens. III. Oral activity of oestriol and its 18-homo analogue in the rat.
  123. The contraceptive action of impeding oestrogens. VII. Effectiveness of oestriol in the rabbit and the hamster.
  124. The contraceptive action of impeding oestrogens: contraceptive action of oestriol through seminal transfer during mating.
  125. The contraceptive action of the (intrauterine) device.
  126. Contraceptive effect of iron. Reduced fertility after vaginal application of iron chloride in rats.
  127. Contraceptive efficacy of single and divided doses of chlormadinone acetate.
  128. Contraceptive intrauterine device coated with copper. [Mehen beluli fogamzasgatlo bevonasa elemi rezzel.]
  129. Contraceptive methods from folk medicine. [Folkemedicinsk antikonception.]
  130. Contraceptive methods: selective factors in a study of dysplasia of the cervix.
  131. Contraceptive pills and venous thrombosis. [P-piller og venos trombose.]
  132. Contraceptive pills.
  133. The contraceptive potential of early versus delayed insertion of the intrauterine device.
  134. Contraceptive practices among college women.
  135. Contraceptive practices and use of family planning services in Costa Rica according to recent studies. [Practica anticonceptiva y uso de los servicios de planificacion familiar en Costa Rica segun encuestas recientes.]
  136. Contraceptive practices in marriage during the nineteenth and twentieth centuries: human problems and religious attitudes. [Les pratiques anticonceptionnelles dans le mariage au 19e etau 20e siecle: problemes humaines at attitudes religieuses.]
  137. Contraceptive practices in marriage during the nineteenth and twentieth centuries: human problems and religious attitudes: part 2. [Les pratiques anticonceptionnelles dans le mariage au 19th and 20th siecle: problemes humaines et attitudes religieuses. 2e partie.]
  138. Contraceptive rings inserted for a long period.
  139. Contraceptive specifications: report on a workshop.
  140. Contraceptive steroids and their mechanism of action.
  141. Contraceptive technology 1971.
  142. Contraceptive technology. Current and prospective methods.
  143. Contraceptive technology: current and prospective methods.
  144. Contraceptive use among single college students.
  145. Contraceptives and endometrium. [Anovulatorios e endometrio.]
  146. Contraceptives.
  147. Contraceptives. Side effects and risks. [Anovulatorios. Fenomenos secundarios y riesgos.]
  148. Contraceptives: use and side effects from a dermatologic viewpoint. [Antikonzeptiva, Anwendung und Nebenwirkungen aus dermatologischer Sicht.]
  149. The contribution of plant-level medical facilities to population and family planning policies in Asia.
  150. Control of oral contraceptive users. [Kontroll av P-pille brukere.]
  151. Control of population growth and family planning.
  152. Control of the birth rate: future of different contraceptive and abortive methods. [Le controle de la natalite: avenir des differentes methodes contraceptives et abortives.]
  153. Correlates of oral contraception continuation.
  154. A cost-effect analysis of the Singapore National Family Planning Program me - July 1967 to December 1970.
  155. Cost-effectiveness analysis as an evaluation technique in family planning programs:
  156. The costs and benefits of family planning programs.
  157. Course of labor after the failure of intrauterine contraception. [Priebeh porodov po zlyhani intrauterinnej antikoncepcie.]
  158. Critical study of new contraceptives. [Etude critique de nouvelles methodes contraceptives.]
  159. The curious history of contraception.

     

  160. Current status of family planning in Canada.
  161. Current tendencies in the development of contraceptive methods. Further observations from a rural area. [Aktuelle Entwicklungstendenz der Empfangnisverhutungsmethoden. Weitere beobachtungen aus einem Landbezirk.]
  162. Current views of the Food and Drug Administration on oral contraceptives.
  163. Cutaneous side effects of oral contraceptives.
  164. Cyclic breakthrough bleeding and bleeding irregularities due to hormonal contraception. [Zyklische Abbruchsblutungen und Blutungsirregularitaeten unter hormonalen Kontrazeptiva.]
  165. Cyclic patterns of gonadotrophin, pregnanediol, and corticoid excretion in women on long-term oral contraceptive therapy.
  166. Cyclical changes in plasma-lysolecithin induced by oral contraceptives.
  167. Cytochemistry of normal vaginal epithelium and under the effect of contraceptive pills in women: enzymmorphology of phosphatases and glycogen in normal vaginal epithelium.
  168. Cytochemistry of normal vaginal epithelium and under the effect of contraceptive pills in women: II. Tapochemistry of nucleic acids and different proteins in normal vaginal epithelium.
  169. The Dai study: the Dai-midwife--a local functionary and her role in family planning.
  170. Dangers of contraception. [Les dangers de la contraception.]
  171. Decreased serum B12 levels secondary to oral contraceptive agents.
  172. Delivering family planning services within a maternal/child health framework: advantages, disadvantages and comments.
  173. Demand for contraceptives in developing countries.
  174. A demographic evaluation of the family planning programme in India.
  175. Department of Health and Family Planning.
  176. Depo Provera as a long-acting contraceptive. [Le Depo Provera en contraception retard.]
  177. Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation.
  178. Depot-gestagens and -estrogens and their use in gynecology and birth control. [Uber Gestagene und Ostrogene mit Depotwirkung und ihre Anwendung in der Gynakologie und Bei der Geburtenregelung.]
  179. Depression and oral contraception.
  180. Dermatologic significance and side effects of oral contraceptives. [Bedeutung und Nebenwirkungen oraler Kontrazeptiva in der Dermatologie.]
  181. Developing male contraceptives.
  182. The development of a family planning program for private patients in a community hospital.
  183. Development of family planning programs in South-East Asian countries.
  184. Diabetes and oral contraceptives. [Diabetes och p-piller.]
  185. Differential fertility and contraception in the urban area of La Paz. [Fecundidad diferencial y anticonception en el area urbana de La Paz.]
  186. Differential role patterns of adoptors in the national family planning programme.
  187. Directory of contraceptives.
  188. Discussion on control of fertility. Contraceptive failures.
  189. Discussion: family planning and the law.
  190. Domiciliary family planning service in Glasgow.
  191. Domiciliary family planning services: a reappraisal.
  192. Dublin's first family planning clinic.
  193. Dynamics of the Muslim-Hindu differential in family planning practices in rural East Pakistan.
  194. Early thrombosis of the central retinal artery and oral contraceptives. [Thrombose precoce de l'artere centrale de la retine et contraceptifs oraux.]
  195. The economic and demographic impact of the Indian Family Planning Program.
  196. Education and training on the health aspects of family planning.
  197. Education in the health aspects of family planning.
  198. The EEG in cerebral ischemic lesions in women taking oral contraceptives.
  199. Efectos colaterales con esteroides anticonceptivos (Side effects of contraceptive steroids)
  200. Effect of a long-acting steroid contraceptive (Medroxyprogesterone Acetate)
  201. Effect of an injectable contraceptive on fertility of a population through a postpartum approach.
  202. The effect of an intrauterine contraceptive device on the mast cell content of the human myometrium: a preliminary report. (Abstract only)
  203. The effect of combined oestrogen-progestogen oral contraceptives, and of their separate components, on plasma levels of renin, renin-substrate, angiotensin, and aldosterone, and on blood pressure.
  204. Effect of contraceptive drugs on blood coagulability. [Ispitivanie dejstva oralnikh kontratseptivnikh sredstva na koagulabilnos t krvi zhena.]
  205. Effect of contraceptive treatment with Ovosiston on serum cholinesterase activity. [Einfluss einer antikonzeptionellen Behandlung mit Ovosiston auf die Cholinesterase-Aktivitat im Serum.]
  206. Effect of estrogen on tubal transport of ova in rats fitted with intrauterine contraceptive suture.
  207. Effect of estrogen-containing oral contraceptives on platelet and plasma ascorbic acid concentrations.
  208. The effect of family planning field workers and incentives on clinic utilization in Indonesia.
  209. The effect of family planning in Georgia on fertility in selected rural counties.
  210. Effect of hormonal contraceptives on blood coagulation and blood vessel walls. and blood vessel walls. [Wirkung der hormonalen Kontrazeptiva auf Blutgerinnung und Gefasswand.]
  211. Effect of hormonal contraceptives on extragenital regulatory mechanisms in humans and in experimental animals. [Beeinflussung extragenitaler Steuerungsmechanismen durch hormonelle Contraceptiva bei Menschen und Versuchstieren.]
  212. Effect of intrauterine contraceptive suture on corpora lutea of guinea pigs.
  213. Effect of oral contraceptive hormones on zinc metabolism in the rat.
  214. Effect of oral contraceptive on glucuronyl transferase.
  215. Effect of oral contraceptive steroids on jejunal pyruvate kinase and adenyl cyclase activities.
  216. Effect of oral contraceptives on blood pressure. (Abstract only)
  217. Effect of oral contraceptives on blood viscosity.
  218. The effect of oral contraceptives on factor 8 levels.
  219. The effect of oral contraceptives on folate metabolism.
  220. Effect of oral contraceptives on human endometrium in culture.
  221. Effect of oral contraceptives on lactation.
  222. Effect of oral contraceptives on patients with Opisthorchis Viverrini (liver fluke) infestation.
  223. Effect of oral contraceptives on quantitative measurements of plasma proteins. [Einfluss oraler Antikonzeptiva auf quantitativ gemessene Plasamproteine.]
  224. The effect of oral contraceptives on serum lipids.
  225. Effect of oral contraceptives on the thromboelastogram. (Abstract only)
  226. Effect of protein deficiency on the response of rat uterus to intrauterine contraceptive suture.
  227. The effect of publicity on contraceptive practice.
  228. The effect of publicity on contraceptive practice. (Abstract only)
  229. The effect of publicity on oral contraceptive practice.
  230. Effect of steroidal contraceptives on antibody formation in the human female.
  231. Effect of time of removal of intrauterine contraceptive devices on implantation and blastocyst survival in the rat.
  232. Effectiveness of contraceptive methods.
  233. The effectiveness of family planning programs in less developed countries: the evidence from survey data.
  234. Effectiveness of oral contraceptives in the hormonal pregnancy test. [Zur Leistungsfahigkeit oraler Kontrazeptiva im hormonalen Schwangerschaftstest.]
  235. The effects induced by steroid contraceptives on milk secretion and mammary glands of the female lactating goats.
  236. Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity.
  237. Effects of depo-medroxyprogesterone acetate as a contraceptive agent.
  238. The effects of gonadal hormones and contraceptive steroids on serum lipids.
  239. Effects of hormonal contraception on plasma phospholipids. [Beeinflussung der Plasmaphosphatide durch hormonelle Kontrazeption.]
  240. Effects of injectable contraceptive progestogens on the puerperal uterus.
  241. Effects of oral contraceptives and estrogens on Antithrombin-III-Activity and other blood coagulation parameters. [Die Wirkung von oralen Kontrazeptiva und Ostrogenen auf die Antithrombin III-Aktivitat und andere Gerinnungsparameter.]
  242. Effects of oral contraceptives on affective fluctuations associated with the menstrual cycle.
  243. Effects of oral contraceptives on carbohydrate and lipid metabolism.
  244. Effects of oral contraceptives on human plasma Vitamin-A levels.
  245. Effects of oral contraceptives on the gingiva.
  246. Effects on blood fibrinolysis of an oral contraceptive low in progestin (Ovulen)
  247. Eighteen months later: family planning services in the United States, 1969.
  248. Electromyographic studies of the human uterus with an intrauterine contraceptive device.
  249. Elephants and butterflies and contraceptives.
  250. Employer`s contribution to family planning and related activities.
  251. Endometrial assessment of relative potency of contraceptive progestational compounds. Mode of action of luteal supplementation. Histochemical study.
  252. Endometrial morphology after prolonged use of hormonal contraceptives.
  253. Endometrial study with combined 17alpha-hydrozy progesterone contraceptives.
  254. Environmental sanitation in the context of family planning.
  255. Enzyme histochemical studies on the endometrium in Ceylonese: including investigation of enzymic alterations developing in the endometrium following treatment with the oral contraceptive Ovulen.
  256. The Esfahan seminar: Report of a regional seminar on functional literacy and family planning education, April-May 6, 1971.
  257. Estimating the need for contraceptive services in the younger age groups.
  258. Estimating the need for subsidized family planning services.
  259. Estimation of births averted by family planning programs; the parity approach.
  260. Estimation of contraceptive continuation functions.
  261. Estrogen-progestagen combinations: selection and utilization in family planning - second part. [Les oestro-progestatifs: leur choix et utilisation dans la planification familiale - deuxieme partie.]
  262. Estrogen-progestagen combinations: their choice and utilization in family planning - first part. [Les oestro-progestatifs: leur choix et utilisation dans la planification familiale - premiere partie.]
  263. An ethno-historic survey of family planning.
  264. Etude statistique a propos de 496 utilisatrices). (Monilial vulvovaginitis and oral contraceptives. Statistical study on 496 users) [Vulvo-vaginites moniliasques et contraceptifs oraux.]
  265. European Social Development Programme: family planning and social policy in Europe.
  266. Evaluating publicly supported family planning services in metropolitan Detroit.
  267. Evaluation and research on the Turkish family planning program (1971)
  268. An evaluation of a family planning programme in a rural area in West Bengal.
  269. Evaluation of a low-dose progestagen as a contraceptive.
  270. Evaluation of deladroxate as a monthly contraceptive injection.
  271. An evaluation of different methods of rural family planning delivery services in Iran: a demonstration study.
  272. Evaluation of family planning programmes.
  273. Evaluation of population policies: a framework for analysis and its application to Taiwan's family planning program.
  274. Evaluation of the contraceptive efficacy of quingestanol acetate.
  275. Evaluation of the efficacy and side effects of a contraceptive containing .5 mg of norethindrone and .1 mg of mestranol in a family planning clinic. [Avaliacao da eficiencia e efeitos secundarios de anovulatorio contendo .5 mg de noretindrone e .1 mg de mestranol em clinica anticoncepcional.]
  276. Evaluation of the rhythm method as a family planning method. 2. Acceptance among low socioeconomic strata in Cali, Colombia. [Evaluacion de la continencia periodica como metodo de planificacion familiar. 2. Aceptacion entre niveles socioeconomicos bajos en Cali, Colombia.]
  277. Evolution mechanism of arterial hypertension during the use of oral contraceptives. [Mekanismen ved utvikling av arteriell hypertensjon under bruk an orale antikonsepsjonsmidler.]
  278. Excretion of tryptophan metabolites as affected by pregnancy, contraceptive steroids, and steroid hormones.
  279. Experience in male contraception.
  280. Experience in the use of infecundin for contraception. [Opyt primeneniya infecundina s tselyu kontratseptsii.]
  281. Experience with tri-monthly injection of depo-medroxyprogesterone acetate as a contraceptive agent. (Abstract only)
  282. Experiences with the intrauterine contraceptive device in Ibadan, Nigeria.
  283. An experiment in reinforced family planning education at clinic level.
  284. Experiments with laboratory animals as models for verifying a tendency to thrombosis during hormonal contraception. [Tierexperimentelle Modelle zur Verifizierung der Thromboseneigung unter hormonalen Kontrazeptiva.]
  285. An exploratory study of troops and their families practising contraception.
  286. The eye and oral contraceptives. [L'oeil et les contraceptifs oraux.]
  287. Facilitating India's family planning program through television: A study of source effectiveness.
  288. Factors affecting the success of a family planning program in a low-income neighborhood in Caracas.
  289. Factors determining husbands attitudes towards family planning.
  290. Factors in adoption of medical contraception and explicit motives of users of local and oral contraceptives. [Facteurs d'adoption de la contraception medicale et motivations explicites des utilisatrices des contraceptifs locaux et oraux.]
  291. Falling birth rates and family planning.
  292. Family planning - how, when and where. [Familjeplanering - hur, nar och var.]
  293. Family planning a Catholic doctor's dilemma.
  294. Family planning acceptance rates in Hong Kong, 1961-69.
  295. Family planning activities: 1969-1970 (Vietnam)
  296. Family planning among health clinic patients in Barbados.
  297. Family planning and abortion -- a new field of applied psychology.
  298. Family planning and American goals.
  299. Family planning and cancer screening as provided by paramedical personnel. (Abstract only)
  300. Family planning and demographic situation in communities of Serbia. [Planirane poroditse i demografska situatsija u opschtinama srbije.]
  301. Family planning and Islam.
  302. Family planning and population dynamics.
  303. Family planning and social change in Muslim culture.
  304. Family planning and social policy in Europe. (Report on the Expert Group Meeting, Karlovy Vary and Prague, Czechoslovakia, October 5-13, 1970; and the Seminar, Kiljava, Finland, May 16-25, 1971.)
  305. Family planning and the demographic situation in the Districts of Croatia.
  306. Family planning as preventive medicine.
  307. The family planning attitudes, practices and motivations of mental patients.
  308. Family planning clinics in Poona City.
  309. Family planning comes of age.
  310. Family planning communications in an extension low-income program.
  311. Family planning education.
  312. Family planning evaluation mission to Ceylon.
  313. Family planning for midwives and nurses.
  314. Family planning for teenagers.
  315. Family planning in China. [Familjeplanering i Kina.]
  316. Family planning in Chingleput District, Madras, India.
  317. Family planning in Ecuador.
  318. Family planning in five continents: Africa, America, Asia, Europe, Oceania.
  319. Family planning in Haiti: the UUSC approach.
  320. Family planning in health services.
  321. Family planning in India: a critique and a perspective.
  322. Family Planning in Iran: four years of progress.
  323. Family planning in Latin America: image and reality.
  324. Family planning in Malaysia: programs and prospects.
  325. Family planning in Santiago, Chile: the male viewpoint.
  326. Family planning in the 1970s: a dynamic force affecting the status of children.
  327. Family planning in the Indian medical curriculum.
  328. Family planning in the People's Republic of China.
  329. Family planning in Trinidad and Tobago in 1970: Preliminary report on the family planning survey-females.
  330. Family planning in Tunisia and Morocco; a summary and evaluation of the recent record.
  331. Family planning in West Virginia public health clinics.
  332. Family planning knowledge, attitude, and practice: a sample survey in Andhra Pradesh.
  333. Family planning motivation through newspapers.
  334. Family planning needs and resources in southeastern Michigan.
  335. Family planning policies and practice in population control.
  336. Family planning practices in India: the first all-India survey report.
  337. Family planning program evaluation: status, problems, prospects.
  338. Family planning program experience in the Republic of China.
  339. Family planning program in Brazil.
  340. Family planning programme in Ceylon.
  341. Family planning programs during last one decade in Korea.
  342. Family planning services.
  343. Family planning variables and family health and adjustment.
  344. Family planning variables and maternal complications with special reference to the grand multipara.
  345. Family planning variables and perinatal and childhood mortality.
  346. Family planning variables and the growth, development, and intelligence of children.
  347. Family planning with special consideration of intrauterine contraception using the Dana-Super type IUD. [Familienplanung unter besonderer Berucksichtigung der intrauterinen Anti konzeption mit dem Intrauterinpessar vom Typ Dana-Super.]
  348. Family planning with special reference to medical aspects.
  349. Family planning with the pill: a manual for nurses.
  350. Family planning within and beyond MCH. (maternal and child health)
  351. (Family planning)
  352. Family planning.
  353. Family planning.
  354. Family Planning.
  355. Family Planning. Preliminary Communication. [Planificacion Familiar. Comunicacion preliminar.]
  356. Family planning. (Tunisia)
  357. Family planning/population research: Thailand.
  358. Family planning: practice and problems. [Familienplanung: Praxis und Probleme.]
  359. Family planning: a study of the attitudes, knowledge, and practice of women in Italy, Belgium, France, Great Britain, and West Germany.
  360. Family planning: an expanded role for paramedical personnel.
  361. Family planning: getting and keeping your program going.
  362. Family planning: improving your existing program.
  363. Family Planning: instructor's manual.
  364. Family planning: program planning.
  365. Family planning: reform and revolution.
  366. Family Planning: the concept.
  367. Fertility after insertion of an IUCD in Taiwan's family planning program.
  368. Fertility and family planning in relation to public health.
  369. The fertility components and contraceptive history techniques for measuring contraceptive use-effectiveness.
  370. Fertility decline and contraceptive use in the International Postpartum Family Planning Program.
  371. Field structures in family planning.
  372. Films as means to promote family planning education and instruction.
  373. Final report: International Workshop on Communications in Family Planning Programs, Teheran, Iran, 6-18 June 1970.
  374. The first 'his-hers' contraceptive.
  375. The first five years of the Singapore National Family Planning Programme, 1966 to 1970.
  376. A five year comparison of the continuation rates between women using loop D and oral contraceptives.
  377. A five year plan for population research and family planning services.
  378. A five year plan for population research and family planning services. 1. Overview. 2. Research. 3. Services.
  379. Five year plan, National Family Planning Project, Ministry of Public Health, 1972-1976.
  380. A five-year plan for population research and family planning services: 2. Population research.
  381. Folic acid deficiency anemia following long-term use of oral contraceptives. [Folsaurenmangelanamie als Folge des langfristigen Gebrauchs peroraler kontrazeptiver Mittel.]

     

  382. Folic acid deficiency in users of oral contraceptive agents. (Abstract only)
  383. Four years' experience with the Lippes Loop as a method of family planning.
  384. A four-year comparison between the utilization and use-effectiveness of sequential and combined oral contraceptives.
  385. A framework for analysis and its application to Taiwan's family planning program.
  386. Functional and compositional bone changes of rats fed the oral contraceptive steroids, mestranol and norethynodrel.
  387. Further advice and directions: (peroral contraception. [Nya rad och anvisningar: Peroral antikonception.]
  388. The future of intrauterine contraception.
  389. The Gbaja Family Health Nurse Project, Lagos, Nigeria, 1967-1970: an examination of its family planning impact.
  390. The genesis of the family planning movement in historical perspective.
  391. Genetic consequences of contraception in Santiago. [Consecuencias geneticas de la anticoncepcion en Santiago.]
  392. Ghetto poor favor birth control.
  393. Glucose and insulin levels during treatment with a combined oral contraceptive agent.
  394. Gynecological contraindications in hormonal contraception) [Gynaekologische Kontraindikationen fuer hormonalen Kontrazeptiva.]
  395. The Hawaii pregnancy, birth control and abortion study: social-psychological aspects.
  396. Health aspects of family planning--integration of family planning services into maternal child and other health services.
  397. Health aspects of family planning.
  398. Health benefits from family planning. [Beneficios para la salud de la planificacion familiar.]
  399. Health benefits of family planning.
  400. Health education in health aspects of family planning.
  401. The health educative role of the nurse in family planning.
  402. Health statistics and family planning: administrative and organizational aspects.
  403. Hemorrhagic papillary edema caused by oral contraceptives. [Oedeme papillaire hemorrhagique par anticonceptionnels oraux.]
  404. Hepatic consequences of oral contraception. [Les consequences hepatiques de la contraception par voie orale.]
  405. Hepatocellular damage following the use of hormonal contraceptives. [Uszkodzenie watroby po hormonalnych srodkach antykoncepcyjnych.]
  406. Hindus and family planning: a socio-political demography.
  407. Historical review of the growth and development of family planning training programs in the Philippines.
  408. The history of family planning in Britain.
  409. History of family planning.
  410. Hong Kong: oral contraceptive follow-up study.
  411. Hormonal contraception and thromboembolic disease: effects of the oral contraceptives on hemostatic mechanisms. A review of the literature.
  412. Hormonal contraception with 0.5 mg chlormadinone acetate by continuous administration.
  413. Hormonal contraceptives and fibroadenomas of breast.
  414. Hormonal evaluation of Czechoslovak contraceptive preparations. [Hormonalni hodnoceni Cs. antikoncepcnich pripravku.]
  415. Hormonal steroid contraceptives I: physiological and pharmacological considerations.
  416. Hormonal steroid contraceptives. IV: Adverse reactions and management of the patient.
  417. Hormonal steroid contraceptives: 3. Adverse reactions.
  418. Hormonal steroid contraceptives: clinical considerations.
  419. Hospital based family planning services in an urban setting.
  420. Hospital-based family planning program.
  421. The Houston story: A vasectomy service in a family planning clinic.
  422. How birth control affects births.
  423. How shall we manage contraceptive advice? [Hur skall vi klara preventivradgivningen?]
  424. How the oral contraceptives work.
  425. Hypertension and oral contraception.
  426. Hypertension and oral contraceptives. [Hypertension och p-piller.]
  427. Hypertension and oral contraceptives. [Hypertension og oral antikonception.]
  428. Hypertension and the oral contraceptives: a report of 19 patients.
  429. Hysterography study of long-term effects of intrauterine contraceptive devices.
  430. Immediate postpartum insertion of a new intrauterine contraceptive device.
  431. Immobilization of human spermatozoa with iron. Basis for a new contraception?
  432. Immunochemical LH determination during treatment with oral and depot contraceptives. [Immunochemische LH-Bestimmung unter Behandlung mit oralen und Depot-Kont razeptiva.]
  433. The impact of desired family size upon family planning practices in rural East Pakistan.
  434. Impact of family planning on birth rate.
  435. The impact of liberalized abortion laws on family planning.
  436. Impact of the family planning programme in Greater Bombay.
  437. Implications of depressed antithrombin-III activity associated with oral contraceptives.
  438. Implications of hyperlipidemia associated with use of oral contraceptives.
  439. Important thing to consider and do about family planning.
  440. Improved contraception in Hungary.
  441. Inadequacy of a one-method family planning program.
  442. Inadequacy of a one-method family planning program.
  443. Incentive payments in family planning programs.
  444. Incentives in family planning program strategy.
  445. Incentives in the diffusion of family planning innovations.
  446. Incidence of breast nodules and changes in breast size during prolonged use of DMPA injections for contraception.
  447. Incidence of thromboembolism in oral contraceptive users in the United Kingdom and Scandinavia.
  448. Increased levels of serum immunoglobulins G and M in women using intrauterine contraceptive devices.
  449. Indications and contraindications for oral contraceptive treatment. [Indikationer og kontraindikationer for behandling med p-piller.]
  450. Individual aspirations as related to early and late acceptance of contraception.
  451. Induced abortion - contraception. [Abortus provocatus - antikonsepsjon.]
  452. Induced abortion and contraception: sociological aspects.
  453. Induced abortion and family planning: gynecological aspects.
  454. The influence of a sequential oral contraceptive on the carbohydrate metabolism of diabetics and pre-diabetics.
  455. The influence of conjugal behavior, migration and contraception on natality in Barbados.
  456. Influence of contraceptives on carbohydrate metabolism in female diabetics. [Zur Frage der Beeinflussung des Kohlenhydratstoffwechsels bei Diabetikerinnen durch Ovulationshemmer.]
  457. Influence of ethanol on the rate of galactose elimination in women taking oral contraceptives and in pregnant women.
  458. Influence of gestogenic contraceptive pills on vaginal candidosis.
  459. The influence of oral contraceptives on carbohydrate and lipid metabolism.
  460. Influence of oral contraceptives on the nasal mucosa. [Influence des contraceptifs oraux sur la muqueuse nasale.]
  461. Influence of oral contraceptives upon the occurrence of Candida albicans in the vagina. [Oral antikonceptions indflydelse pa forekomstem af Candida albicans i vagina.]
  462. Influence of various hormonal contraceptives on sperm migration in vivo.
  463. Influence of various oral contraceptives on the hormone secretion of the hypophysis and ovary in fertile women. [Der Einfluss verschiedener oraler Kontrazeptiva auf die hypophsaere und ovarielle Hormonausscheidung der geschlechtreifen Frau.]
  464. Initiation of contraception immediately postpartum: an epidemiologic analysis.
  465. Injectable contraceptives in family planning - clinical experience in 14,958 cycles.
  466. Inquiry into psychiatric incidents due to oral contraception. [Le psychiatrie et la pilule. Enquete sur les incidences psychiatriques de la contraception orale.]
  467. Instruction in family planning and related subjects in European medical schools.
  468. Instruction in family planning at the University of Puerto Rico School of Medicine.
  469. Instruction in the techniques of family planning at Cornell University Medical College.
  470. Instruction manual for the POPCOM family planning record-keeping system.
  471. Integration of family planning with a public health department.
  472. Integration of family planning with maternity and child health services.
  473. An intensive community program for contraception.
  474. Inter-state variations in the cost-effectiveness of family planning during 1969-70 (India)
  475. Internal medicine contraindications in hormonal contraception. [Internistische Kontraindikationen der hormonalen Antikonzeption.]
  476. International cooperation in family planning.
  477. The International Planned Parenthood Federation.
  478. International postpartum family planning program.
  479. Interpersonal communication and the diffusion of family planning in West Malaysia.
  480. Intra-uterine contraception with a new Antigon model, and investigation of the mechanics of action of intra-uterine devices.
  481. Intra-uterine contraceptive devices in general practice.
  482. Intraperitoneal contraceptive device removal via colpotomy.
  483. Intrauterine contraception and its complications. [La contraception intra-uterine et ses complications.]
  484. Intrauterine contraception. IV . Personal experiences and evaluation of intrauterine contraception. [Intrauterine Empfangnisverhutung. Teil IV: Eigene Erfahrungen und Einsch atzung der intrauterinen Kontrazeption.]
  485. Intrauterine contraception. [Intrauterin antikonception.]
  486. Intrauterine contraception. [Vnutrimatochnaya kontratseptsiya.]
  487. Intrauterine contraception. 2. Mode of action and use of modern intrauterine devices. [Intrauterine Empfangnisverhutung. 2. Wirkungs- und Anwendungsweise der modernen Intrauterinpessare.]
  488. intrauterine contraception. I. Historical development. [Intrauterine Empfangnisverhutung. Teil I: Historische Entwicklung.]
  489. Intrauterine contraception. III. Effectiveness and side effects of modern IUDs. [Intrauterine Empfangnisverhutung. Teil III: Wirksamkeit und Nebenwirkung en der modernen Intrauterinpessare.]
  490. Intrauterine contraceptive devices; a compilation of devices.
  491. Intrauterine devices for contraception: the IUD.
  492. Introduction of the "pregnancy zone" protein by oral contraceptives.
  493. Introduction. (Public and private opinion of elites on birth control programs.)
  494. Introduction. (Birth control, religion and the law.)
  495. Introduction. (The public's private opinions on birth control programs.)
  496. Investigation of the possible relationship between oral contraceptives and benign and malignant breast disease.
  497. Investments in family planning.
  498. Is it safe (Oral contraception)
  499. Ischaemic colitis and the contraceptive pill.
  500. Islamic attitudes to contraceptive methods.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.